CAS: 692737-80-7
![4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydro…](https://static.cymitquimica.com/products/IN/thumb/DA006NEX.jpg)
4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate
CAS:692737-80-7
Formula:
C24H27FN6O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
482.5074
Ref: IN-DA006NEX
| 1mg | 65.00 € | ||
| 5mg | 122.00 € | ||
| 10mg | 192.00 € | ||
| 25mg | 232.00 € | ||
| 50mg | 559.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dovitinib Lactate Salt
CAS:692737-80-7
Formula:
C21H21FN6O·C3H6O3
Purity:
99.98% (Typical Value in Batch COA)
Color and Shape:
yellow-brown solid
Molecular weight:
482.51g/mol
Ref: 54-BIFK0016
| 5mg | 92.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Dovitinib lactate
CAS:692737-80-7
Dovitinib lactate (TKI-258 lactate)(TKI258) lactate is a potent inhibitor of fibroblast growth factor receptor 3 …
Formula:
C24H27FN6O4
Purity:
98.44% - 99.54%
Color and Shape:
Solid
Molecular weight:
482.51
Ref: TM-T7104
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 127.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 350.00 € | ||
| 200mg | 523.00 € | ||
| 500mg | 828.00 € | ||
| 1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Dovitinib Lactate
Controlled ProductCAS:692737-80-7
Applications Dovitinib is used in treating melanoma. References Renhowe, P., et al.: J. Med. Chem., …
Formula:
C21H21FN6O·C3H6O3
Color and Shape:
Neat
Molecular weight:
392.43 + 90.08
Ref: TR-D537000
| 10mg | 260.00 € | ||
| 25mg | 399.00 € | ||
| 50mg | 707.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Dovitinib Lactate Salt
CAS:692737-80-7
Dovitinib is a tyrosine kinase inhibitor that is used for the treatment of non-small cell …
Formula:
C24H27FN6O4
Purity:
Min. 95%
Molecular weight:
482.51 g/mol
Ref: 3D-SCB73780
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
